BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, Tomao S. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2010; 2(9): 348-359 [PMID: 21160806 DOI: 10.4251/wjgo.v2.i9.348]
URL: https://www.wjgnet.com/1948-5204/full/v2/i9/348.htm
Number Citing Articles
1
Anastasios J. Karayiannakis, Stylianos Kakolyris, Alexandra Giatromanolaki, Nikos Courcoutsakis, Helen Bolanaki, Leonidas Chelis, Efthimios Sivridis, Constantinos Simopoulos. Hepatoid Adenocarcinoma of the GallbladderJournal of Gastrointestinal Cancer 2012; 43(S1): 139 doi: 10.1007/s12029-011-9326-5
2
Qun Wang, Yan-Jun Zhong, Jing-Ping Yuan, Li-Hua Shao, Jue Zhang, Li Tang, Shao-Ping Liu, Ya-Ping Hong, Raymond A Firestone, Yan Li. Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical studyJournal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-192
3
Yichao Mo, Yaoyong Lu, Peng Wang, Simin Huang, Longguang He, Dasheng Li, Fuliang Li, Junwei Huang, Xiaoxia Lin, Xueru Li, Siyao Che, Qinshou Chen. Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinomaTumor Biology 2017; 39(2): 101042831769099 doi: 10.1177/1010428317690999
4
坤 钱. Bevacizumab: Current Approach in the Treatment of Hepatocellular CarcinomaMedical Diagnosis 2011; 1(01): 1 doi: 10.12677/md.2011.11001
5
Wei-Cheng Liang, Jia-Lin Ren, Cheuk-Wa Wong, Sun-On Chan, Mary Miu-Yee Waye, Wei-Ming Fu, Jin-Fang Zhang. LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signalingOncogene 2018; 37(11): 1445 doi: 10.1038/s41388-017-0041-y
6
William Wei Sharr, See Ching Chan, Chung-Mau Lo. Section 3. Current Status of Downstaging of Hepatocellular Carcinoma Before Liver TransplantationTransplantation 2014; 97(Supplement 8S): S10 doi: 10.1097/01.tp.0000446267.19148.21
7
Jian Wang, Chang-Peng Zhu, Ping-Fang Hu, Hui Qian, Bei-Fang Ning, Qing Zhang, Fei Chen, Jiao Liu, Bin Shi, Xin Zhang, Wei-Fen Xie. FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibitionCarcinogenesis 2014; 35(11): 2576 doi: 10.1093/carcin/bgu180
8
Anju Mullath, Murali Krishna. Hepatocellular carcinoma – time to take the ticketWorld Journal of Gastrointestinal Surgery 2019; 11(6): 287-295 doi: 10.4240/wjgs.v11.i6.287
9
ZhongYu Jiang, Zhen Mao. Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinomaviaWnt/β-catenin signaling pathwayRSC Advances 2019; 9(61): 35473 doi: 10.1039/C9RA05933D
10
T.J. Vogl, F. Marquardt, W. Bechstein, J. Trojan, N.N.N. Naguib, T. Gruber-Rouh, M. Beeres, C. Lee. Interventionelle Therapie primärer LebertumorenDer Onkologe 2012; 18(7): 593 doi: 10.1007/s00761-012-2237-7
11
Tianyi Xu, LiPing Wang, Peilin Jia, Xiaofeng Song, Zhongming Zhao. An Integrative Transcriptomic and Methylation Approach for Identifying Differentially Expressed Circular RNAs Associated with DNA Methylation ChangeBiomedicines 2021; 9(6): 657 doi: 10.3390/biomedicines9060657
12
Jianyong Lei, Wentao Wang, Lunan Yan. Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan CriteriaJournal of Gastrointestinal Surgery 2013; 17(8): 1440 doi: 10.1007/s11605-013-2229-y
13
Suling Chen, Fang Li, Haiyun Chai, Xin Tao, Haili Wang, Aifang Ji. miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gammaBiochemical and Biophysical Research Communications 2015; 464(2): 500 doi: 10.1016/j.bbrc.2015.06.168
14
FU-BIAO KANG, LING WANG, DONG LI, YIN-GE ZHANG, DIAN-XING SUN. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expressionOncology Reports 2015; 33(1): 274 doi: 10.3892/or.2014.3587
15
Hao Cai, Wentao Kong, Tie Zhou, Yudong Qiu. Radiofrequency Ablation Versus Reresection in Treating Recurrent Hepatocellular CarcinomaMedicine 2014; 93(22): e122 doi: 10.1097/MD.0000000000000122
16
Li-Li Zhang, Yan-Jun Guo, Chun-Na Zhao, Jian-Yun Gao. Effects and mechanism of miR–214 on hepatocellular carcinomaAsian Pacific Journal of Tropical Medicine 2015; 8(5): 392 doi: 10.1016/S1995-7645(14)60350-3
17
YuXiang Fang, Jing-Lun Xue, Qi Shen, Jinzhong Chen, Ling Tian. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinomaHepatology 2012; 55(6): 1852 doi: 10.1002/hep.25576
18
Sihyung Wang, Youngmi Jung. Potential Role of Hedgehog Signaling in Radiation-induced Liver FibrosisJournal of Life Science 2013; 23(5): 710 doi: 10.5352/JLS.2013.23.5.710
19
Xinfeng Fan, Haiyuan Du, Yaogui Sun, Junbing Jiang, Zhirui Wang, Wei Yin, Kuohai Fan, Hongquan Li. Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetinOncology Letters 2017; 14(2): 1731 doi: 10.3892/ol.2017.6364
20
Juhyun Kim, Ranhui Won, Guyee Ban, Mi Ha Ju, Kyung Sook Cho, Sang Young Han, Jin-Sook Jeong, Seong-Wook Lee. Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA RegulationScientific Reports 2015; 5(1) doi: 10.1038/srep12315
21
Dan-dan Xiong, Yi-wu Dang, Peng Lin, Dong-yue Wen, Rong-quan He, Dian-zhong Luo, Zhen-bo Feng, Gang Chen. A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinomaJournal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1593-5
22
Meng Gao, Hong Xu, Xu Bao, Chenghong Zhang, Xin Guan, Hongyan Liu, Li Lv, Sa Deng, Dongyan Gao, Changyuan Wang, Yan Tian. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancerLife Sciences 2016; 165: 63 doi: 10.1016/j.lfs.2016.09.008
23
Alissa Hendricks-Wenger, Sofie Saunier, Alexander Simon, Douglas Grider, David Luyimbazi, Irving C. Allen, Eli Vlaisavljevich. Histotripsy for the Treatment of Cholangiocarcinoma in a Patient-Derived Xenograft Mouse ModelUltrasound in Medicine & Biology 2022; 48(2): 293 doi: 10.1016/j.ultrasmedbio.2021.10.002
24
Minhee Kim, Su-Bin Kim, Jaehi Kim, Keun-Sik Kim, Dong-Eun Kim. Co-delivery of curcumin and PTTG1 siRNA by galactose receptor-targeted liposomes for enhanced anti-tumor effects in hepatocellular carcinomaJournal of Drug Delivery Science and Technology 2023; 86: 104692 doi: 10.1016/j.jddst.2023.104692
25
Alireza Mafi, Hamidreza Rismanchi, Mohaddese Malek Mohammadi, Neda Hedayati, Seyedeh Sara Ghorbanhosseini, Seyed Ali Hosseini, Yasaman Gholinezhad, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Fatemeh Zarepour, Seyed Pouya Taghavi, Zatollah Asemi, Mina Alimohammadi, Hamed Mirzaei. A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progressionFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1224138
26
Ka Wing Ma, Kenneth Siu Ho Chok, Wong Hoi She, Albert Chi Yan Chan, Tan To Cheung, Wing Chiu Dai, James Yan Yue Fung, Chung Mau Lo. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched AnalysisLiver Transplantation 2018; 24(8): 1062 doi: 10.1002/lt.25033
27
Alissa Hendricks-Wenger, Peter Weber, Alex Simon, Sofie Saunier, Sheryl Coutermarsh-Ott, Douglas Grider, Joan Vidal-Jove, Irving Coy Allen, David Luyimbazi, Eli Vlaisavljevich. Histotripsy for the Treatment of Cholangiocarcinoma Liver Tumors: In Vivo Feasibility and Ex Vivo Dosimetry StudyIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 2021; 68(9): 2953 doi: 10.1109/TUFFC.2021.3073563
28
Laura Contreras, Alfonso Rodríguez-Gil, Jordi Muntané, Jesús de la Cruz. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer CellsCancers 2022; 14(5): 1204 doi: 10.3390/cancers14051204
29
NAZIM SERDAR TURHAL, BERNA SAVAŞ, ÖZNUR ÇOŞKUN, EMINE BAŞ, BÜLENT KARABULUT, DENIZ NART, TANER KORKMAZ, DILEK YAVUZER, GÖKHAN DEMIR, GÜLEN DOĞUSOY, MEHMET ARTAÇ. Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot studyMolecular and Clinical Oncology 2015; 3(6): 1275 doi: 10.3892/mco.2015.633
30
A Thelen, C Benckert, H-M Tautenhahn, H-M Hau, M Bartels, J Linnemann, J Bertolini, M Moche, C Wittekind, S Jonas. Liver resection for hepatocellular carcinoma in patients without cirrhosisJournal of British Surgery 2013; 100(1): 130 doi: 10.1002/bjs.8962
31
Vickie C. Kong, Michael Velec. Stereotactic Body Radiation Therapy for Liver Cancer: A Review of the TechnologyJournal of Medical Imaging and Radiation Sciences 2015; 46(3): 343 doi: 10.1016/j.jmir.2015.06.005
32
Y-J Liao, H-Y Bai, Z-H Li, J Zou, J-W Chen, F Zheng, J-X Zhang, S-J Mai, M-S Zeng, H-D Sun, J-X Pu, D Xie. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cellsCell Death & Disease 2014; 5(3): e1137 doi: 10.1038/cddis.2014.66
33
Wei-Cheng Liang, Cheuk-Wa Wong, Pu-Ping Liang, Mai Shi, Ye Cao, Shi-Tao Rao, Stephen Kwok-Wing Tsui, Mary Miu-Yee Waye, Qi Zhang, Wei-Ming Fu, Jin-Fang Zhang. Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathwayGenome Biology 2019; 20(1) doi: 10.1186/s13059-019-1685-4
34
Rodrigo Martins Abreu, Camila Silva Ferreira, Paulo Dominguez Nasser, Luciana Oba Onishi Kikuchi, Flair José Carrilho, Suzane Kioko Ono. Hepatocellular Carcinoma: The Final Moments of LifeJournal of Cancer Therapy 2013; 4(02): 377 doi: 10.4236/jct.2013.42A045
35
Weiwen Chen, Yurong Qiu. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular CarcinomaCell Biochemistry and Biophysics 2015; 72(2): 325 doi: 10.1007/s12013-014-0456-9
36
Erkan Kahraman, Erdem Göker. Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathwaysMolecular Biology Reports 2022; 49(6): 4377 doi: 10.1007/s11033-022-07273-9
37
T.J. Vogl, B. Panahi, S. Fischer, N. Naguib, N.-E.A. Nour-Eldin, T. Gruber, J. Trojan, W. Bechstein, S. Zangos, K. Eichler. Interventionelle Therapie von Lungen- und LebermetastasenDer Onkologe 2014; 20(8): 746 doi: 10.1007/s00761-014-2669-3
38
Wing Chiu Dai, Tan To Cheung. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrenceExpert Review of Anticancer Therapy 2016; 16(10): 1063 doi: 10.1080/14737140.2016.1226136
39
Thomas Yau, Hilda Wong, Pierre Chan, T. J. Yao, R. Pang, T. T. Cheung, S. T. Fan, Ronnie T. Poon. Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseInvestigational New Drugs 2012; 30(6): 2384 doi: 10.1007/s10637-012-9808-8
40
Dipanwita Sengupta, Kaustav Dutta Chowdhury, Avik Sarkar, Soumosish Paul, Gobinda Chandra Sadhukhan. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinomaBiochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1): 219 doi: 10.1016/j.bbagen.2013.08.020
41
Tejaswi Worlikar, Eli Vlaisavljevich, Tyler Gerhardson, Joan Greve, Shanshan Wan, Sibu Kuruvilla, Jonathan Lundt, Kimberly Ives, Timothy Hall, Theodore H. Welling, Fred Lee, Zhen Xu. Histotripsy for Non-Invasive Ablation of Hepatocellular Carcinoma (HCC) Tumor in a Subcutaneous Xenograft Murine Model2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2018; : 6064 doi: 10.1109/EMBC.2018.8513650
42
John Chun-Hao Chen, Hui-Yen Chuang, Fei-Ting Hsu, Yi-Chen Chen, Yi-Chun Chien, Jeng-Jong Hwang. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse modelOncotarget 2016; 7(51): 85450 doi: 10.18632/oncotarget.13398
43
Jian‐Bo Xu, Fu‐Zhen Qi, Gang Xu, Guo‐Feng Chen, Ming‐De Huang, Jian‐Huai Zhang. Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus‐related hepatocellular carcinoma: A meta‐analysisHepatology Research 2014; 44(2): 209 doi: 10.1111/hepr.12109
44
A. Bauschke, A. Altendorf-Hofmann, M. Freesmeyer, T. Winkens, C. Malessa, J.-H. Schierz, U. Teichgraeber, U. Settmacher. Selektive interne Radioembolisation beim nichtresektablen hepatozellulären KarzinomDer Chirurg 2016; 87(11): 956 doi: 10.1007/s00104-016-0259-1
45
Shital S. Panchal, Somsuvra B. Ghatak, Abhishek B. Jha, Raoul Onattu. Reduction of liver tumerogenic effect of N-nitrosodiethylamine by treatment with ɣ-oryzanol in Balb/C miceEnvironmental Toxicology and Pharmacology 2017; 56: 86 doi: 10.1016/j.etap.2017.08.006
46
YUQING CHEN, AIMIN HUANG, MEIQIN GAO, YONGQIN YAN, WENMIN ZHANG. Potential therapeutic value of dendritic cells loaded with NY-ESO-1 protein for the immunotherapy of advanced hepatocellular carcinomaInternational Journal of Molecular Medicine 2013; 32(6): 1366 doi: 10.3892/ijmm.2013.1510
47
Chengshuo Zhang, Baomin Chen, Ao Jiao, Feng Li, Ning Sun, Guoqing Zhang, Jialin Zhang. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinomaBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5016-z
48
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego, José L. Mauriz. Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00151
49
RUI WU, LIANG DUAN, LIWEI YE, HAIYANG WANG, XIA YANG, YUNYUAN ZHANG, XIAN CHEN, YAN ZHANG, YAGUANG WENG, JINGYONG LUO, MIN TANG, QIONG SHI, TONGCHUAN HE, LAN ZHOU. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathwayInternational Journal of Oncology 2013; 42(3): 1001 doi: 10.3892/ijo.2013.1796
50
Lisha Chen, Hongbing Yao, Kai Wang, Xiangfeng Liu. Long Non‐Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR‐143‐3p and Promotes Hepatocellular Carcinoma ProgressionJournal of Cellular Biochemistry 2017; 118(12): 4836 doi: 10.1002/jcb.26158
51
Erik S. Knudsen, Purva Gopal, Amit G. Singal. The Changing Landscape of Hepatocellular CarcinomaThe American Journal of Pathology 2014; 184(3): 574 doi: 10.1016/j.ajpath.2013.10.028
52
Linlin Lu, Juan Zhou, Jian Shi, Xiao-juan Peng, Xiao-xiao Qi, Ying Wang, Fang-yuan Li, Fu-Yuan Zhou, Liang Liu, Zhong-Qiu Liu, Qinghua Sun. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma PatientsPLOS ONE 2015; 10(5): e0127524 doi: 10.1371/journal.pone.0127524
53
K.W. Ma, A.C.Y. Chan, B.W.H. She, K.S.H. Chok, T.T. Cheung, J.W.C. Dai, J.Y.Y. Fung, C.M. Lo. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage TransplantationTransplantation Proceedings 2018; 50(4): 1087 doi: 10.1016/j.transproceed.2018.01.025
54
Breno Boueri Affonso, Francisco Leonardo Galastri, Joaquim Mauricio da Motta Leal Filho, Felipe Nasser, Priscila Mina Falsarella, Rafael Noronha Cavalcante, Marcio Dias de Almeida, Guilherme Eduardo Gonçalves Felga, Leonardo Guedes Moreira Valle, Nelson Wolosker. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstagingWorld Journal of Gastroenterology 2019; 25(37): 5687-5701 doi: 10.3748/wjg.v25.i37.5687
55
Yaqin Lu, Zhe Li, Chen Lin, Jian Zhang, Zhisen Shen. Translation role of circRNAs in cancersJournal of Clinical Laboratory Analysis 2021; 35(7) doi: 10.1002/jcla.23866
56
Anupam Bishayee, Roslin J. Thoppil, Animesh Mandal, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Erzsébet Háznagy‐Radnai, Judit Hohmann, Deepak Bhatia. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine‐initiated hepatocarcinogenesis by suppression of the inflammatory responseMolecular Carcinogenesis 2013; 52(4): 304 doi: 10.1002/mc.21860
57
L. V. Klotz, M. E. Eichhorn, B. Schwarz, H. Seeliger, M. K. Angele, K.-W. Jauch, Christiane J. Bruns. Targeting the vasculature of visceral tumors: novel insights and treatment perspectivesLangenbeck's Archives of Surgery 2012; 397(4): 569 doi: 10.1007/s00423-012-0946-4
58
A N Gordon-Weeks, A Snaith, T Petrinic, P J Friend, A Burls, M A Silva. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteriaBritish Journal of Surgery 2011; 98(9): 1201 doi: 10.1002/bjs.7561
59
Won‐Chul Lim, Hyunhee Kim, Hyeonseok Ko. Delphinidin inhibits epidermal growth factor‐induced epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cellsJournal of Cellular Biochemistry 2019; 120(6): 9887 doi: 10.1002/jcb.28271
60
Ping Fang, Jin-hua Hu, Zhi-gang Cheng, Zhe-feng Liu, Jin-liang Wang, Shun-chang Jiao, Xiaolin Zi. Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II TrialsPLoS ONE 2012; 7(12): e49717 doi: 10.1371/journal.pone.0049717
61
Sara Carbajo-Pescador, Andrés García-Palomo, Javier Martín-Renedo, Maiara Piva, Javier González-Gallego, José L. Mauriz. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptorJournal of Pineal Research 2011; 51(4): 463 doi: 10.1111/j.1600-079X.2011.00910.x
62
Monika Pazgan-Simon, Sylwia Serafinska, Justyna Janocha-Litwin, Krzysztof Simon, Jolanta Zuwala-Jagiello. Diagnostic Challenges in Primary Hepatocellular Carcinoma: Case Reports and Review of the LiteratureCase Reports in Oncological Medicine 2015; 2015: 1 doi: 10.1155/2015/878763
63
Xu Bao, Meng Gao, Hong Xu, Ke-Xin Liu, Cheng-Hong Zhang, Ni Jiang, Qiu-Chen Chu, Xin Guan, Yan Tian. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatmentDrug Development and Industrial Pharmacy 2015; 41(7): 1193 doi: 10.3109/03639045.2014.938081
64
Ka Wing Ma, Tan To Cheung. When to Consider Liver Transplantation in Hepatocellular Carcinoma Patients?Hepatic Oncology 2017; 4(1): 15 doi: 10.2217/hep-2016-0010
65
Qian Lei, Lidan Zhang, Yong Xia, Tinghong Ye, Fangfang Yang, Yongxia Zhu, Xuejiao Song, Ningyu Wang, Ying Xu, Xiaowei Liu, Luoting Yu. A novel benzothiazole derivative SKLB826 inhibits human hepatocellular carcinoma growth via inducing G2/M phase arrest and apoptosisRSC Advances 2015; 5(52): 41341 doi: 10.1039/C5RA05387K
66
Mostafa M. Shakweer, Abdelshafy A. Awad Allah, Abdel-Aziz K. Aun. Common interventional techniques (single versus combined) in management of hepatocellular carcinomaThe Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(4): 1407 doi: 10.1016/j.ejrnm.2016.07.001
67
Tejaswi Worlikar, Mishal Mendiratta-Lala, Eli Vlaisavljevich, Ryan Hubbard, Jiaqi Shi, Timothy L. Hall, Clifford S. Cho, Fred T. Lee, Joan Greve, Zhen Xu. Effects of Histotripsy on Local Tumor Progression in an in vivo Orthotopic Rodent Liver Tumor Model BME Frontiers 2020; 2020 doi: 10.34133/2020/9830304